Nucleai (www.nucleaimd.com), and Merck KGaA, Darmstadt, Germany, announced that they have entered into a long-term collaboration to leverage Nucleai’s image analysis and biomarker discovery platform for several Merck KGaA, Darmstadt, Germany clinical stage oncology assets.
June 24, 2021
· 2 min read